A
Amicus Therapeutics, Inc. (FOLD)
NGM – Real Time Price. Currency in USD
14.49
+14.49 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
14.49
+14.49 (0.00%)
At close: Apr 24, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.84 | 6.05 | 10 | |
| Quick ratio | 1.88 | 5.63 | 9.0 | |
| Debt to Equity | 1.61 | 0.30 | 4.0 | |
| Debt to Assets | 0.47 | 1.04 | 5.0 | |
| Interest coverage | 1.40 | -16.91 | 4.0 | |
| Weighted average score | 6.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 329M | 399M | 528M | 634M | 634M |
| Gross Profit | 285M | 354M | 467M | 554M | 554M |
| Operating Income | -204M | -73M | 34M | 34M | 34M |
| Net Income | -237M | -152M | -56M | -27M | -27M |
| EBITDA | -199M | -66M | 43M | 42M | 42M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | 30.7 | 166.67 | 10 |
| Next quarter | 18.78 | 208.33 | 9.5 |
| Current year | 18.84 | 496.3 | 9.5 |
| Next year | 18.95 | 79.44 | 9.5 |
| Weighted average score | 9.6 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 9.55 | -90.22 | -83.32 | -54.77 | 2.3 |
| Y/Y | 23.72 | -88.52 | -79.99 | 479.5 | 5.5 |
| 3y average | 24.55 | 50.2 | 50.84 | 95.29 | 10 |
| 5y average | 19.7 | 33.13 | 35.48 | 63.21 | 9.8 |
| Weighted average score | 6.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $442.4M significantly exceeds cash reserves ($214.0M), raising financial stability concerns
Total current assets $676.2M exceed Total current liabilities $237.8M, highlighting excellent liquidity
Debt-to-equity ratio (1.6) far exceeds the industry average, reflecting over-leverage
Interest coverage ratio (1.4x) is dangerously low, suggesting debt repayment risks
The company generates positive free cash flow $16.0M, supporting its financial health